Viewing nowSharplan Tablets 100 mg (Sarpogrelate Hydrochloride)
Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Samik Pharmaceutical Co., Ltd.

MFDS item code 201603033 · Approved 2016.05.30 · Insurance code 644003740
Improvement of ischemic symptoms such as chronic arterial occlusion (ulcer, pain, etc.)
This medication is used to improve ischemic symptoms such as ulcers, pain, and cold sensation caused by chronic arterial occlusion, including Buerger's disease, occlusive arterial disease, and diabetic peripheral vascular disease. It enhances blood circulation, increases blood flow in peripheral blood vessels, and alleviates pain and cold sensation. Through these effects, it helps reduce the discomfort experienced in patients' daily lives and ultimately improves symptoms.
As Sarpogrelate Hydrochloride, take 100 mg orally after meals three times a day. Adjust dosage as appropriate based on symptoms.
This medication should not be used in patients with bleeding. This is because the risk of bleeding may increase in conditions with a high risk of bleeding, such as hemophilia, capillary disorders, gastrointestinal ulcers, and urinary tract bleeding. Women who are pregnant or may become pregnant should not take this medication as animal studies have shown potential harm to the fetus. Women who are menstruating or patients with a tendency for bleeding should use this medication with caution due to the risk of worsening bleeding. Patients taking anticoagulants or antiplatelet agents should be cautious as the risk of bleeding may increase when taken with this medication. Patients with significantly impaired kidney function should use this drug cautiously as it may not be adequately excreted from the body. Elderly patients may have weakened kidney and liver function, which could increase the risk of elevated blood concentration of this medication; therefore, it is advisable to start with a lower dose and closely monitor their condition. During the course of this medication, severe bleeding symptoms such as gastrointestinal bleeding, cerebral hemorrhage, and subcutaneous bleeding should be carefully monitored. If any abnormal symptoms occur, the medication should be discontinued immediately and medical consultation should be sought. Abnormalities in blood cell counts, such as agranulocytosis or thrombocytopenia, may occur; thus, regular blood tests are necessary. Liver function may be impaired, or jaundice may present, so liver function should be periodically assessed. Allergic reactions such as skin rash, urticaria, and itching may occur, and if symptoms appear, the medication should be discontinued. Gastrointestinal symptoms such as vomiting, stomatitis, heartburn, abdominal pain, and diarrhea may occur, and patients should notify healthcare professionals if these symptoms arise. Symptoms such as palpitations, shortness of breath, and chest pain may occur, requiring caution. Neurological symptoms such as drowsiness, headache, and dizziness may occur, so caution is required when driving or operating machinery. The safety of this medication has not been established in children, and it is advisable not to use it in pediatric patients. This medication should be stored out of reach of children and should not be transferred to other containers, as maintaining the quality is important.
Bleeding tendency (gastrointestinal bleeding, cerebral hemorrhage, subcutaneous bleeding, etc.), agranulocytosis, anemia, thrombocytopenia, leukopenia, acute hepatitis, liver dysfunction, jaundice, erythema, urticaria, rash, redness, papules, itching, dyspnea
Vomiting, stomatitis, nausea, foreign body sensation (in the esophagus), heartburn, abdominal pain, constipation, loss of appetite, abdominal bloating, diarrhea, palpitations, chest pain, facial flushing, hand swelling, drowsiness, altered taste, headache, dizziness, proteinuria, hematuria, elevated BUN, elevated creatinine, pharyngitis, throat discomfort, burning sensation in the throat, weight gain, elevated serum triglycerides, elevated serum cholesterol, decreased serum albumin, decreased serum calcium, glucosuria, urine sediment,
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or humidity, so it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. This will help retain the medication's effectiveness for longer.
White round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Samik Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Yuhan Corporation

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
(Co., Ltd.) Pharmgen Science

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Haewon Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.